The aforementioned products are not registered under the Pharmacy and Poisons Ordinance or the Traditional Chinese Medicine Ordinance
Figure 4 demonstrates the full geographical spread of post locations
Lynda Scammell, the head of borderline products at the MHRA, said: Where medicinal claims are made, or products are being used in a way which brings them within the definition of a medicinal product under the Human Medicines Regulations 2012, a peptide-containing product must hold a marketing authorisation to be legally sold or supplied in the UK
They aid in recovery from acne scars, sun-damaged dryness, or minor epidermal injuries, restoring healthy glow
In patients with T2D in a phase 2 clinical trial, retatrutide (0.5 to 12 mg) significantly reduced body weight and HbA1c levels compared to placebo and 1.5 mg dulaglutide
This article provides general legal information and is not intended as legal advice